Craig Milne Purchases 135,000 Shares of Innovotech (CVE:IOT) Stock

Innovotech Inc. (CVE:IOT) Director Craig Milne acquired 135,000 shares of the company’s stock in a transaction that occurred on Friday, July 3rd. The shares were acquired at an average price of C$0.08 per share, for a total transaction of C$10,800.00. Following the purchase, the director owned 1,733,615 shares of the company’s stock, valued at C$138,689.20. This trade represents a 8.44% increase in their ownership of the stock.

Innovotech Stock Performance

Shares of CVE IOT opened at C$0.09 on Thursday. The company has a quick ratio of 5.81, a current ratio of 2.63 and a debt-to-equity ratio of 12.55. The firm’s 50-day moving average price is C$0.13 and its two-hundred day moving average price is C$0.19. Innovotech Inc. has a 52-week low of C$0.08 and a 52-week high of C$0.34. The stock has a market capitalization of C$4.90 million, a P/E ratio of -13.22 and a beta of 2.64.

About Innovotech

Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.